CompletedNot Applicable

Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations

United States42 participantsStarted 2018-10-05

Plain-language summary

The overarching plan for TOWER is to develop and test an algorithmic version of the Center for Disease Control Guidelines (CDCG) tailored for a specific primary care setting, the HIV primary care clinic. This CDCG intervention incorporates communication and implementation strategies tailored for the HIV primary care setting, and enabled with technology (an app for use by patients and EMR tools for providers).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Attending physician or advance practice provider in one of the Institute of Advanced Medicine (IAM) clinics * Designated PCP for at least 5 patients to whom he/she prescribes opioids * Willing and able to adhere to study procedures including randomization, and refraining from discussion of study procedures with other clinical staff or patients Exclusion Criteria: * Unwillingness to undergo randomization * Plans to leave IAM within the study period.

What they're measuring

Proportion of eligible PCPs who successfully complete randomization

Timeframe: 18 months

Trial details

NCT IDNCT03669939

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-09-30

View on ClinicalTrials.gov More HIV Disease trials